期刊文献+

糖尿病对大鼠心肌缺血预处理保护作用的影响 被引量:7

Influence of diabetes on the protective effect of ischemic preconditioning on ischemic reperfused rat heart
暂未订购
导出
摘要 目的探讨糖尿病对缺血预适应(IPC)在大鼠缺血再灌注心肌保护作用中的影响。方法取糖尿病SD大鼠及非糖尿病SD大鼠各30只,分为非糖尿病对照组(A组)、非糖尿病缺血再灌注组(B组)、非糖尿病IPC组(C组)、糖尿病对照组(D组)、糖尿病缺血再灌注组(E组)、糖尿病IPC组(F组),每组10只。动物处死后建立离体心脏Langendorff灌注模型。对照组采用全心灌流90min,余不做任何处理;缺血再灌注组采用心脏平衡灌流30min后,缺血30min,再复灌30min;IPC组采用心脏平衡灌流10min,经2次缺血5min再灌注5min后,缺血30min,再复灌30min。比较各组复灌30min后心排血量(CO)、左室发展压(LVDP)、左室内压最大上升和下降速率(±dp/dtmax)的恢复率,检测缺血前及复灌30min后冠脉流出液中肌酸激酶(CK)的活性和心肌组织中丙二醛(MDA)、超氧化物歧化酶(SOD)的含量,并计算心肌含水率。结果与非糖尿病缺血再灌注组比较,非糖尿病IPC组CK活性、MDA含量、心肌含水率均明显降低,SOD含量明显增加,CO、LVDP、+dp/dtmax、-dp/dtmax恢复率明显增加(P<0.05)。而糖尿病IPC组与糖尿病缺血再灌注组比较上述变化均不明显(P>0.05)。结论糖尿病可抑制IPC对大鼠缺血再灌注心肌的保护作用。 Objective To explore the influence of diabetes on the protective effect of ischemic preconditioning (IPC) on ischemic. reperfused (IR) myoeardium of rat. Methods Sixty male SD rats (30 with diabetes and 30 without diabetes) were divided into six groups (10 each) : non-diabetic rats control group (group A), non-diabetic rats IR group (group B), non-diabetic rats IPC group (group C), dia- betic rats control group (group D), diabetic rats IR group (group E) and diabetic rats IPC group (group F). The isolated heart perfusion Langendorff models were established after rats were sacrificed. Isolated hearts of the two control groups were undergone a 90rain perfusion without any other intervention; those of the two IR groups were undergone a 30rain equilibration period, a 30min isehemia and a 30min reperfusion; those of the two IPC groups were undergone a 10min equilibration, then elicited by two cycles of 5rain ischemia interspersed with 5min reperfusion prior to 30rain ischemia and a a0min reperfusion. The recovery rates of the left ventricular function, such as cardiac output (CO) and left ventricular developed pressure (LVDP), and the maximum upstroke and decay velocities of left ventricular pressure (±dp/dtmax) were recorded. The activity of creatine kinase (CK) in coronary outflow, contents of malonyldialdehyde (MDA) and super- oxide dismutase (SOD) in myocardium were detected, and myocardial water ratio were assessed. Results In non diabetic rats IPC group, the activity of CK, content of MI)A and water ratio of myocardium declined significantly, while the content of SOD increased and the recovery rates of CO, LVDP and ±dp/dtmax rose significantly compared with that in non-diabetic rats IR group (P〈0. 05). However, no significant difference was found between group E and group F when compared on those parameters (P〉0.05). Conclusion Diabetes may inhibit the protective effect of ischemic preconditioning on ischemic reperfused rat heart.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2008年第10期1195-1197,共3页 Medical Journal of Chinese People's Liberation Army
关键词 糖尿病 缺血预适应 心肌再灌注损伤 diabetes mellitus ischemic preconditioning myocardial reperfusion injury
  • 相关文献

参考文献7

  • 1Murry CE, Jennings RB, Reimer KA. Prcconditioning with ischemia: a delay of lethal cell injury in ischemicmyocardium. Circulation, 1986, 74(5): 1124
  • 2薛涛,张宜乾,孔明.前列腺素E_1对未成熟心肌缺血-再灌注损伤心肌超微结构变化的影响[J].中国胸心血管外科临床杂志,2004,11(4):269-272. 被引量:8
  • 3Bandyopadhyay D, Chatopadyay A, Ghosh G, et al. Oxidative stress-induced ischemic heart disease: protection by antioxidants. Curr Med Chem, 2004, 11(3): 369
  • 4de Valle HF, Lascano EC, Negroni JA. et al, Absence of ischemic preconditioning protection in diabetic sheep beans: role of sarcolemmal KATP channel dysfunction. ,Viol Cell Biochem, 2003, 249(1-2): 21
  • 5Murphy F,. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardiopro tection. Circ Res, 2004, 94(1): 7
  • 6季永,喻田,李宗权,刘兴奎,陈其斌,余志豪.缺血预处理对大鼠离体缺血再灌注心脏心肌功能和线粒体ATP敏感性钾通道的影响[J].中华麻醉学杂志,2006,26(3):238-241. 被引量:14
  • 7Asano G, Takashi E, Ishiwata T, et al. Palhogenesis and protection of ischemia and reperfusion injury in myocardium.J Nippon Med Sch, 2003, 70(5): 384

二级参考文献16

  • 1Mehrabi MR, Serbecic N, Tamaddon F, et al. Clinical benefit of prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium. Biomed Pharmacother, 2003 ,57(3-4):173-178.
  • 2Ramesh V,Kresch MJ,Katz AM,et al.Characterization of Ca2+-release channels in fetal and adult rat hearts. Am J Physiol, 1995,269(3Pt2):H778-H782.
  • 3Chen F, Ding S, Lee BS,et al. Sarcoplasmic reticulum Ca2+-ATPase and cell contraction in developing rabbit heart. J Mol Cell Cardiol, 2000,32(5): 745-755.
  • 4Yamamoto T, Habuchi Y, Tanaka H,et al. EP receptor-mediated inhibition by prostaglandin E(1)of cardiac L-type Ca2+-current of rabbits. Am J Physiol, 1999, 277(4Pt2): H1369-H1374.
  • 5Ozcan C, Bienengraeber M, Dzeja PP,et al. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol,2002,282(2): H531-H539.
  • 6Reiter R, Resch U, Sinzinger H. Do human platelets express COX-2 ? Prostaglandins Leukot Essent Fatty Acids, 2001, 64(6):299-305.
  • 7Warot D, Berlin II, Aymard G, et al. Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspects. Fundam Clin Pharmacol, 2000,14(3): 231-236.
  • 8Mehrabi MR, Serbecic N, Tamaddon F, et al . Revascularization of myocardial scar tissue following prostaglandin E1-therapy in patients with ischemic heart disease. Pathol Res Pract,2003,199(3):129-136.
  • 9Flameng W, Borgers M, Daenen W. Itrastrutural and cytochemical correlates of myocardial protection by ardiachypothermia in man. J Thorac Cardiovasc Surg, 1980,79:413-424.
  • 10Garlid KD, Paucek P, Yarov Yarovey V, et al. Cardioprotection effects of dizoxide and its interaction with mitochondrial ATP-sensitive K^+ channel. Cir Res, 1997, 81: 1072-1082.

共引文献20

同被引文献50

  • 1文重远,陈小琳,吴勇,杨静,刘永明,詹春,李庚山.改善胰岛素抵抗对糖尿病大鼠心肌能量代谢及心功能的影响[J].中华糖尿病杂志(1006-6187),2005,13(3):199-200. 被引量:6
  • 2Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemi a: a delay of lethal cell injury in ischemicmyocardium[J]. Circulation 1986, 74(5): 1124- 1136.
  • 3Feuvray D. Diabetic cardiomyopathy[J].Arch Mal Coeur Vaiss 2004. 97(3): 261- 265.
  • 4Bandyopadhyay D, Chattopadyay A, Ghosh G, et al. Oxidative stress-induced isehemic heart disease: protection by antioxidants[J]. Curr Med Chem, 2004, 11(3): 369-387.
  • 5Puigserver P, Spiegelman BIVI. Peroxisome proliferator-activated re ceptor-γ coactivator 1a (PCK2-1a): transcriptional coactivator and metabolic regulator[J].Endocrine Rev, 2003, 24 (1) :78-90.
  • 6Hara K, Tobe K, Okada T, et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type 2 diabetes[J]. Diabetologia, 2002, 45(5) : 740-743.
  • 7Lochner A, Marais E, Genade S, et al. Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol,2000,279 : H2752 - H2765.
  • 8Hart HG, Wang ZW, Zhang NB, et al. Roles of nitric oxide during early phase of myocardial ischemic preconditioning in rats. Chin Med J(Engl) ,2005,121:1210 - 1214.
  • 9Bandyopadhyay D, Chattopadyay A, Ghosh G, et al. Oxidative stress-induced ischemic heart disease: protection by antioxidants.Curr Med Chem, 2004,11:369 - 387.
  • 10Han JS, Wang HS, Yah DM, et al. Myocardial ischaemic and di- azoxide preconditioning both increase PGC-1 alpha and rduce mito- chondrial damage. Acta Cardiol, 2010,65:639 - 644.

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部